Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with non-small cell lung cancer, confirmed through a laboratory test of tissue samples
- People for whom chemotherapy and/or immunotherapy has been recommended as a treatment
- People who own and are able to use a smartphone that has a step-counting feature
- People who are willing to carry their smartphone close to their body at all times during the trial
- People who are 18 years of age or older
- People who are willing and able to provide written consent to participate
- People who have the mental capacity to understand and agree to participate in the trial
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have small-cell lung cancer (a different type of lung cancer)
- People whose general health and ability to perform daily activities falls below a certain level, as measured by a standard medical scoring system (confirm with trial site)
- People who have had chest surgery within the 3 months before starting chemotherapy and/or immunotherapy
- People who are not expected to be able to follow the trial's requirements consistently
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dirk Rades, Prof. Dr. med., University of Lubeck
Phone: 0049-451-500
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
Mean number of steps per week performed at baseline and during the first three cycles of chemo- and/or immunotherapy for lung cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 10 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.